Australian Centre for Research on Separation Science, School of Applied Sciences, RMIT University, City Campus, G.P.O. Box 2476, Melbourne, VIC. 3001, Australia.
J Chromatogr A. 2010 Jan 1;1217(1):127-35. doi: 10.1016/j.chroma.2009.10.075. Epub 2009 Oct 30.
The application of comprehensive two-dimensional gas chromatography coupled to time-of-flight mass spectrometry (GCxGC-TOFMS) for the analysis of six anabolic agents (AAs) in doping control is investigated in this work. A non-polar-polar column configuration with 0.2microm film thickness (d(f)) second dimension ((2)D) column was employed, offering much better spread of the components on (2)D when compared to the alternative 0.1microm d(f)(2)D column. The proposed method was tested on the "key" AA that the World Anti-Doping Agency (WADA) had listed at the low ngmL(-1) levels (clenbuterol, 19-norandrosterone, epimethendiol, 17alpha-methyl-5alpha-androstane-3alpha,17beta-diol, 17alpha-methyl-5beta-androstane-3alpha,17beta-diol and 3'-OH-stanozolol). The compounds were spiked in a blank urine extract obtained by solid-phase extraction, hydrolysis and liquid-liquid extraction; prior to analysis they were converted to the corresponding trimethylsilyl (TMS) derivatives. The limit of detection (LOD) was below or equal to the minimum required performance limit (MRPL) of 2ngmL(-1) defined by WADA, and the correlation coefficient was in the range from 0.995 to 0.999. The method allows choosing an ion from the full mass spectra which shows the least interference from the matrix and/or the best sensitivity; this can only be done if full scan mass spectral data are available. The advantage of GCxGC over classical one-dimensional GC (1D GC), in terms of separation efficiency and sensitivity, is demonstrated on a positive urine control sample at a concentration of 5ngmL(-1). The obtained similarity to the in-house created TOFMS spectra library at this level of concentration was in the range from 822 to 932 (on the scale from 0 to 999). Since full mass spectral information are recorded, the method allows the retro-search of non-target compounds or new "designer steroids", which cannot be detected with established GC-MS methods that use selected ion monitoring (SIM) mode.
本工作研究了全二维气相色谱与飞行时间质谱联用(GCxGC-TOFMS)在兴奋剂检测中分析六种合成代谢剂(AAs)的应用。采用 0.2μm 薄膜厚度(d(f))的非极性-极性二维(2D)柱作为第二维(2D)柱,与替代的 0.1μm d(f)(2)D 柱相比,该二维柱在 2D 上的组分展宽效果更好。该方法在世界反兴奋剂机构(WADA)在低 ngmL(-1) 水平列出的“关键”AA(克仑特罗、19-去甲雄烷酮、表美雄醇、17α-甲基-5α-雄烷-3α,17β-二醇、17α-甲基-5β-雄烷-3α,17β-二醇和 3'-OH-雄甾醇)上进行了测试。这些化合物被加入固相萃取、水解和液-液萃取得到的空白尿液提取物中;在分析之前,它们被转化为相应的三甲基硅烷(TMS)衍生物。检测限(LOD)低于或等于 WADA 定义的 2ngmL(-1)的最低性能要求限值(MRPL),相关系数在 0.995 到 0.999 之间。该方法允许从全质谱中选择一个显示出最小基质干扰和/或最佳灵敏度的离子;只有在获得全扫描质谱数据的情况下才能做到这一点。与传统的一维气相色谱(1D GC)相比,GCxGC 在分离效率和灵敏度方面具有优势,在浓度为 5ngmL(-1)的阳性尿液对照样品中得到了证明。在这个浓度水平下,与内部创建的 TOFMS 光谱库的相似度在 822 到 932 之间(在 0 到 999 的范围内)。由于记录了全质谱信息,该方法允许对非目标化合物或新的“设计类固醇”进行追溯搜索,而这些化合物无法用使用选择离子监测(SIM)模式的现有 GC-MS 方法检测到。